Globus Medical
Globus Medical to pay $53m for key supplier Branch Medical
Globus, up on Q3 beat, surprises with CFO resignation
COV will likely divest some vascular therapies ahead of MDT merger | The week in medtech M&A
Globus Medical snaps up allograft maker Transplant Technologies
J&J’s Synthes wins another round against Globus, ex-sales rep
Globus Medical posts a strong 1st quarter following robotic surgery entry
Globus Medical (NYSE:GMED) got some Wall Street love after reporting a strong 1st quarter, during which the company notched the acquisition of Excelsius Surgical.
Globus Medical gains a bit on strong Q4 prelims
Globus Medical (NYSE:GMED) blew the doors off of the sluggish growth rate for the spinal implant market during the 4th quarter, topping Wall Street’s expectations and sending share prices up today.
Globus Medical gets into robotic surgery with Excelsius Surgical acquisition
J&J’s Synthes wins round in spat with ex-sales rep
Globus Medical gains on Q3 results, raised earnings guidance
Globus Medical (NYSE:GMED) shares gained this week after the medical device company reported strong 3rd-quarter results ahead of Wall Street’s expectations and raised its earnings outlook for the rest of the year.